°¡±Ý·ù ÀǾàǰ ½ÃÀå : µ¿¹° À¯Çüº°, Á¦Ç°º°, Áúº´ À¯Çüº°, Åõ¿© °æ·Îº°, Áö¿ªº° - ¿¹Ãø(-2029³â)
Poultry Medicine/Pharmaceuticals Market by Animal Type, Product, Disease Indication, Route of Administration - Global Forecast to 2029
»óǰÄÚµå : 1647383
¸®¼­Ä¡»ç : MarketsandMarkets
¹ßÇàÀÏ : 2025³â 01¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 425 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,950 £Ü 7,162,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,650 £Ü 9,621,000
PDF (5-user License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,150 £Ü 11,792,000
PDF (Corporate License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÀÌ¿ë Àοø¿¡ Á¦ÇÑÀº ¾øÀ¸³ª, ±¹³»¿¡ ÀÖ´Â »ç¾÷À常 ÇØ´çµÇ¸ç, ÇØ¿Ü ÁöÁ¡ µîÀº Æ÷ÇÔµÇÁö ¾Ê½À´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 14,469,000
PDF (Global License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. (100% ÀÚȸ»ç´Â µ¿ÀÏ ±â¾÷À¸·Î °£Áֵ˴ϴÙ.) Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

°¡±Ý·ù ÀǾàǰ ½ÃÀå ±Ô¸ð´Â ¿¹Ãø ±â°£ µ¿¾È 5.9%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î 2024³â 50¾ï 1,000¸¸ ´Þ·¯¿¡¼­ 2029³â¿¡´Â 66¾ï 8,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÅÈï±¹¿¡¼­ °¡±Ý·ù ¹× ±× Á¦Ç°ÀÇ ¼Òºñ°¡ Áõ°¡ÇÔ¿¡ µû¶ó °¡±Ý·ù »çÀ° ¹æ¹ýÀÌ Áõ°¡ÇÏ¿© °¡±Ý·ù ÀǾàǰ ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ¿øÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. °¡±Ý·ù Áúº´, ƯÈ÷ ´ºÄ³½½º´°ú Ä۽õãÁõ Áõ°¡´Â ¹é½Å, Ç×»ýÁ¦, ¸é¿ªÁõ°­Á¦ÀÇ Çʿ伺À¸·Î À̾îÁö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½Äǰ ¾ÈÀü¿¡ ´ëÇÑ °ü½É Áõ°¡¿Í Ç×»ýÁ¦ »ç¿ë °¨¼Ò·Î ÀÎÇØ ¸¹Àº °¡±Ý·ù ³óÀåÀÌ ÇÁ·Î¹ÙÀÌ¿Àƽ½º¿Í º¸´Ù È¿°úÀûÀÎ ¹é½Å°ú °°Àº ´ëü ¿ä¹ý¿¡ ÀÇÁ¸Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °³¹ßµµ»ó±¹ÀÇ °¡±Ý·ù »ý»ê·® Áõ°¡´Â Áö¼Ó °¡´ÉÇÏ°í ¾ÈÀüÇÏ¸ç »ý»êÀûÀÎ °¡±Ý·ù »çÀ°¿¡ ±â¿©ÇÏ´Â È¿°úÀûÀÎ ÀǾàǰ¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù.

Á¶»ç ¹üÀ§
Á¶»ç ´ë»ó ¿¬µµ 2024-2029³â
±âÁØ ¿¬µµ 2023³â
¿¹Ãø ±â°£ 2024-2029³â
°ËÅä ´ÜÀ§ ±Ý¾×(¹ÌÈ­)
ºÎ¹® µ¿¹° À¯Çüº°, Á¦Ç°º°, Áúº´ À¯Çüº°, Åõ¿© °æ·Îº°, Áö¿ªº°
´ë»ó Áö¿ª ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, Áß³²¹Ì, Áßµ¿/¾ÆÇÁ¸®Ä«

µ¿¹° À¯Çüº°·Î´Â ´ß ºÎ¹®ÀÌ °¡±Ý·ù ÀǾàǰ ½ÃÀå¿¡¼­ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ´ß°í±â³ª °è¶õ°ú °°Àº ´Ü¹éÁú °ø±Þ¿øÀÎ ±¹³» °¡±Ý·ù ¼Òºñ·®ÀÌ ¸¹±â ¶§¹®ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ ƯÈ÷ °³¹ßµµ»ó±¹¿¡¼­´Â ´ß »ý»êÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ´ß »çÀ°ÀÇ ¿¬·É´ë°¡ º¯È­Çϰí ÀÖ½À´Ï´Ù. ´ßÀº ¶ÇÇÑ ´ºÄ³½½º´, Àü¿°¼º ±â°üÁö¿°, Ä۽õãÁõ µî ¿©·¯ Áúº´¿¡ °É¸®±â ½±½À´Ï´Ù. ÀÌ´Â ¹é½Å, Ç×»ýÁ¦ ¹× ÇÁ·Î¹ÙÀÌ¿Àƽ½º¸¦ »ç¿ëÇÏ¿© ´ß ¶¼ÀÇ °Ç°­°ú »ý»ê¼ºÀ» Çâ»ó½Ã۱â À§ÇØ ¹é½Å, Ç×»ýÁ¦ ¹× ÇÁ·Î¹ÙÀÌ¿Àƽ½º¸¦ »ç¿ëÇÏ´Â °ÍÀ» ¼³¸íÇÕ´Ï´Ù. in-ovo ¹é½Å Á¢Á¾°ú °°Àº ¹é½Å Åõ¿© ¹æ¹ýÀÇ Çõ½ÅÀº ´ë±Ô¸ð ¿¹¹æ Á¢Á¾ÀÇ È¿À²¼º°ú È¿°ú¸¦ Çâ»ó½ÃŰ°í °¡±Ý·ù ÀǾàǰ ¼Òºñ¿¡ ´õ ¸¹Àº °æ·Î¸¦ Á¦°øÇÕ´Ï´Ù.

Á¦Ç°º°·Î´Â ´ºÄ³½½º´, Àü¿°¼º ±â°üÁö¿°, Á¶·ù ÀÎÇ÷翣ÀÚ µî ´ë±Ô¸ð ¾ç°èÀå¿¡¼­ ºü¸£°Ô È®»êµÇ´Â Àü¿°º´ ¿¹¹æ¿¡ ÇʼöÀûÀÎ ¹é½ÅÀº ÀÌ ½ÃÀå¿¡¼­ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. °¡±Ý·ù¿¡ ´ëÇÑ È¿°úÀûÀÎ ¹é½Å Á¢Á¾Àº °¡±Ý·ùÀÇ °Ç°­, »ý»ê¼ºÀ» º¸ÀåÇÏ°í ¼öÀÇÇÐ ´ç±¹ÀÇ ÃÖÁ¾ÀûÀÎ µµÅ ¸í·ÉÀ¸·Î ÀÎÇÑ ¼Õ½ÇÀ» ÃÖ¼ÒÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù. Ç×»ýÁ¦ »ç¿ë·®À» ÁÙÀÌ·Á´Â ±ÔÁ¦ ¾Ð·ÂÀ¸·Î ÀÎÇØ Ç×±ÕÁ¦ ³»¼ºÀ» Áõ°¡½ÃŰÁö ¾Ê°í °¨¿°À» ¿¹¹æÇÒ ¼ö ÀÖ´Â ¹é½ÅÀº Áúº´ °ü¸®¿¡¼­ ¼±È£µÇ´Â ¼±ÅÃÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¿Àº¸ ¹é½Å Á¢Á¾°ú °°Àº ±â¼úÀÇ ¹ßÀüÀ¸·Î È¿À²ÀûÀÎ Áý´Ü ¿¹¹æÁ¢Á¾ÀÌ °¡´ÉÇØÁü¿¡ µû¶ó ¹é½Å Á¢Á¾Àº ½Ç¿ëÀûÀÌ°í ´ë±Ô¸ð °¡±Ý·ù ³óÀå±îÁö È®´ëµÉ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. Áúº´ ¿¹¹æ°ú Áö¼Ó °¡´ÉÇÑ ³ó¹ý Ãø¸é¿¡¼­ ¹é½ÅÀº °¡±Ý·ù ÀǾàǰ ½ÃÀå¿¡¼­ °¡Àå Å« ºÎ¹®À¸·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù.

Áúº´Àº ¼¼°è °¡±Ý·ù¿¡ ¿µÇâÀ» ¹ÌÄ¡°í °¡±Ý·ù ³ó°¡¿¡ ½É°¢ÇÑ °æÁ¦Àû ¿µÇâÀ» ¹ÌÄ¡±â ¶§¹®¿¡ ÀÌ ½ÃÀå¿¡¼­ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÏ´Â °ÍÀº ´ºÄ³½½º´ÀÔ´Ï´Ù. »ç¸Á·üÀÌ ³ô°í ¹ßº´À¸·Î ÀÎÇÑ »ý»ê¼º ¼Õ½ÇÀÌ Å©±â ¶§¹®¿¡ ¹é½Å Á¢Á¾ ÇÁ·Î±×·¥ÀÌ ÇÊ¿äÇÕ´Ï´Ù. µû¶ó¼­ ´ºÄ³½½º´¿¡ ´ëÇÑ ¹é½ÅÀº °¡±Ý·ù °Ç°­ °ü¸®¿¡ ÇʼöÀûÀÔ´Ï´Ù. 2¼¼´ë ÀçÁ¶ÇÕ ¹é½Å°ú ³»¿­¼º ¹é½ÅÀº »ç¿ë ÆíÀǼºÀÌ Çâ»óµÇ¾î Áý¾àÀû ¾ç°è°¡ ÀÌ·ç¾îÁö´Â ±¹°¡¿¡¼­ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. Áúº´ ¿¹¹æ°ú Á¤ºÎÀÇ ºÀ¼â ÇÁ·Î±×·¥ÀÌ °è¼Ó °­Á¶µÇ¸é¼­ ´ºÄ³½½º´Àº °¡±Ý·ù ÀǾàǰ ½ÃÀå¿¡¼­ °¡Àå Å« Ä«Å×°í¸®·Î ÀÚ¸® Àâ°í ÀÖ½À´Ï´Ù.

Åõ¾à °æ·Îº°·Î º¸¸é, °¡±Ý·ù ÀǾàǰÀÇ °æ±¸ Åõ¿© °æ·Î´Â ¹°À̳ª »ç·á¸¦ ÅëÇØ ¾à¹°À» Àü´ÞÇϱ⠶§¹®¿¡ ´Ù¸¥ °æ·Î¿¡ ºñÇØ ´ë±Ô¸ð ±ºÁý¿¡¼­ È¿À²ÀûÀÌ°í Æí¸®Çϸç, °³º° Á¶·ù¿¡ ´ëÇÑ ½Ã°£°ú ½ºÆ®·¹½º°¡ ¸¹Àº Ãë±Þ ¾øÀÌ ¸ðµç Á¶·ù¿¡ µ¿µîÇÑ ¾çÀÇ ¾à¹°À» Àü´ÞÇÒ °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù. ¸ðµç Á¶·ù¿¡°Ô µ¿ÀÏÇÑ ¿ë·®À» Àü´ÞÇÒ °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù. °æ±¸ Åõ¿©´Â Ç×»ýÁ¦, ¹é½Å, ÇÁ·Î¹ÙÀÌ¿Àƽ½º, ºñŸ¹ÎÁ¦ µî¿¡ °¡Àå ÀûÇÕÇϸç, ¸Å¿ì ´Ù¾çÇÑ ¿¹¹æ ¹× Ä¡·á ¹æ¹ýÀ¸·Î »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ÀΰǺñ Àý°¨, ¾à¹° Åõ¿©ÀÇ ´Ü¼øÈ­, ½Å¼ÓÇϰí È¿°úÀûÀÎ Áúº´ °ü¸®°¡ Áß¿äÇÑ ´ë±Ô¸ð °¡±Ý·ù ½Ã½ºÅÛ¿¡¼­ ÀÌ °æ·Î¸¦ »ç¿ëÇÏ´Â °ÍÀº ÀÌ °æ·Î¸¦ ¸Å¿ì ¼ö¿ëÇϱ⠽±µµ·Ï ¸¸µì´Ï´Ù. °æ±¸ Åõ¿©¿¡ µû¸¥ ½Ç¿ë¼º°ú ±Ô¸ðÀÇ °æÁ¦¸¦ °í·ÁÇÒ ¶§, ÀÌ ¹æ¹ýÀº ¾ç°è »ç¾÷ÀÇ ÁÖÃàÀ» Çü¼ºÇϰí ÀǾàǰ/ÀǾàǰ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ¼¼°è °¡±Ý·ù ÀǾàǰ ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, µ¿¹° À¯Çüº°, Á¦Ç°º°, Áúº´ À¯Çüº°, Åõ¿© °æ·Îº°, Áö¿ªº° µ¿Çâ, ½ÃÀå ÁøÃâ±â¾÷ ÇÁ·ÎÆÄÀÏ µîÀ» Á¤¸®ÇÑ º¸°í¼­ÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ÇÁ¸®¹Ì¾ö ÀλçÀÌÆ®

Á¦5Àå ½ÃÀå °³¿ä

Á¦6Àå °¡±Ý·ù ÀǾàǰ ½ÃÀå(µ¿¹° À¯Çüº°)

Á¦7Àå °¡±Ý·ù ÀǾàǰ ½ÃÀå(Á¦Ç°º°)

Á¦8Àå °¡±Ý·ù ÀǾàǰ ½ÃÀå(Áúȯ À¯Çüº°)

Á¦9Àå °¡±Ý·ù ÀǾàǰ ½ÃÀå(Åõ¿© °æ·Îº°)

Á¦10Àå °¡±Ý·ù ÀǾàǰ ½ÃÀå(Áö¿ªº°)

Á¦11Àå °æÀï ±¸µµ

Á¦12Àå ±â¾÷ °³¿ä

Á¦13Àå ºÎ·Ï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The poultry medicine/pharmaceuticals market is projected to reach USD 6.68 billion by 2029 from USD 5.01 billion in 2024, at a CAGR of 5.9% during the forecast period. The increasing consumption of poultry and its products from the developing countries is mainly responsible for the growth of poultry medicine/pharmaceuticals market as it results in increased poultry farming practices. The rise in illnesses in poultry, especially Newcastle disease and Coccidiosis, leads to the need for vaccines, antibiotics, and immune boosters. Also, the growing attention towards food safety and the reduction of antibiotics, has made many farms to resort to alternative therapies such as probiotics and more effective vaccines. Furthermore, the growing rates of poultry production amongst developing countries increases the demand for efficacious medicine/pharmaceuticals, which contributes to the sustainable, safe and productive poultry keeping.

Scope of the Report
Years Considered for the Study2024-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD)
SegmentsAnimal Type, Product, Disease Indication, Route of Administration, and Region
Regions coveredNorth America, Europe, APAC, LATAM, and MEA (GCC Countries, RoMEA)

"By animal type, chickens segment is expected to have the largest market share in the poultry medicine/pharmaceuticals market."

Based on animal type, the chickens segment is expected to hold the largest market share in the poultry medicine/pharmaceuticals market. Owing to high domestic poultry consumption of protein sources like chicken meat and eggs. This increase in demand has contributed change in age to the poultry farming especially in developing areas with an increase in the production of chickens. Chickens are also commonly affected by several diseases; Newcastle disease, Infectious Bronchitis and Coccidiosis, which explains the use of vaccines, antibiotics and probiotics to enhance the health and productivity of the flocks Several factors attributed to increasing food production also explain the need for higher standards biologically and on farm bio-security interventions. Innovations in vaccine delivery methods such as in ovo vaccination have enhanced the efficiency and effectiveness of immunization on a large scale providing more avenues for consumption of poultry medicine/pharmaceuticals.

"By product, vaccine segment is expected to have the largest market share in the poultry medicine/pharmaceuticals market."

Based on product, the largest share of this market is vaccines since they are critical in the prevention of infectious diseases which can rapidly spread through large flocks, like Newcastle disease, Infectious Bronchitis, and Avian Influenza. Effective vaccination of a poultry flock ensures health, productivity, and minimization of losses due to eventual flock culling order by the veterinary authority. Regulatory pressure to lower the use of antibiotics makes vaccines a preferred choice in the management of diseases as they prevent infections without adding to antimicrobial resistance. Technology advancement, such as ovo vaccination, allows for efficient mass immunization; thus, vaccine administration has become practical and scalable to large poultry farms. In the context of disease prevention and sustainable farming practices, vaccines have cemented their position as the largest segment in the poultry medicine/pharmaceuticals market.

"By disease indication, newcastle disease segment is expected to have the largest market share in the poultry medicine/pharmaceuticals market."

Based on disease indication, the largest share of this market is newcastle disease since the disease affects the poultry worldwide and severely impacts poultry farmers economically. High mortality rates and losses in productivity due to outbreak required vaccination programmes; therefore, vaccines against Newcastle disease are indispensable in poultry health management. Second-generation recombinant and thermostable vaccines have helped increase the ease of use and thus their usage in countries with intensive poultry farming. The continued emphasis on disease prevention and government containment programs have made Newcastle Disease the largest category in the poultry medicine/pharmaceuticals market.

"By route of administration, oral segment is expected to have the largest market share in the poultry medicine/pharmaceuticals market."

Based on route of administration, The oral route of administration in poultry medicine/pharmaceuticals is efficient and convenient in the medication of large flocks in comparison to the other routes as it delivers medication through either water or feed, thereby getting an equal amount of dose delivery to all birds without time-consuming and stressful individual birds' handling. The oral route is most suited for antibiotics, vaccines, probiotics, and vitamins and therefore used in a very diversified preventive and therapeutic mode of application. Labor cost-cutting, simplification in dosing, and accommodation in large-scale poultry systems where quick effective management of disease is important make this route highly acceptable. Given the practicality and economies of scale involved in oral delivery, this mode forms the mainstay in the poultry farming business and commands the market for medicine/pharmaceuticals.

"By region, North America region is expected to have the largest market share in the poultry medicine/pharmaceuticals market."

The poultry medicine/pharmaceuticals market is dominated by North America as a result of advanced poultry farming systems prevalent in the region, high poultry products intake, and greater concern for biosecurity and disease control. The region is characterized by existing legislation that encourages responsible antibiotic use and as a consequence drive producers to vaccines and other health solutions in the production of food. Continuous investments in research and development as well as modern technologies put in place for the management and therapy of diseases further promotes upward movement of this market. On top of that, due to the fact that there is a growing need for sustainable as well as high-yield systems of poultry rearing, the production of medicines that assist in maintaining flocks health and productivity has increased in the region thereby further entrenching North America's market leader position.

A breakdown of the primary participants (supply-side) for the poultry medicine/pharmaceuticals market referred to for this report is provided below:

Prominent players in the poultry medicine/pharmaceuticals market are are MSD (US), Elanco (US), Boehringer Ingelheim (Germany), Ceva Sante Animale (France), Zoetis Service LLC (US), Virbac (France), Phibro Animal Health (US), Hester Biosciences Limited (India), Meiji Animal Health (Japan), Venky's India (India), Bimeda Corporate (Ireland), Calier (Spain), Hipra (Spain), Vetanco (Argentina), Vaxxinova (Netherlands), Biovac Group (Israel), Kemin Industries (US), O.L.KAR Agrozoovet Service (Ukraine), Indovax (India), Avimex (Mexico), Synthese Elevage (France), Provet Pharma Pvt Ltd (India), Huvepharma (Bulgaria), Romvac Company (Romania), and VMN Pharmaceuticals (Turkey).

Research Coverage:

The report analyzes the poultry medicine/pharmaceuticals market and aims at estimating the market size and future growth potential of this market based on various segments such as animal type, product, route of administration and region. The report also includes a competitive analysis of the key players in this market along with their company profiles, service offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall poultry medicine/pharmaceuticals market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:

TABLE OF CONTENTS

1 INTRODUCTION

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

6 POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE

7 POULTRY PHARMACEUTICALS MARKET, BY PRODUCT

8 POULTRY PHARMACEUTICALS MARKET, BY DISEASE TYPE

9 POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION

10 POULTRY PHARMACEUTICALS MARKET, BY REGION

11 COMPETITIVE LANDSCAPE

12 COMPANY PROFILES

13 APPENDIX

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â